But will it? In Hollywood, many executives only pay attention to the wider world when they’re trying to goose the international take of their superhero movies. Can a best-picture breakthrough like “Parasite” transform the way business is done, or will it seem like a blip in 10 years’ time?

Certainly, it should pay dividends for Bong, who emerges from Oscar night an A-list auteur. Already a major cinematic figure in South Korea and a critics’ favorite elsewhere, Bong has had a tricky time of it since he came to Hollywood: Harvey Weinstein nearly buried his U.S. debut “Snowpiercer” when Bong wouldn’t agree to major revisions, and his starry follow-up, “Okja,” went to Netflix when no other studio was eager to finance an effects-laden genre hybrid with a significant amount of scenes in Korean.

But after the success of “Parasite,” which could soon become the fourth highest-grossing foreign-language film of all time in the United States, Bong will join an elite group of international directors like Guillermo del Toro and Alfonso Cuarón who can command top-tier interest from Hollywood. Already, HBO won a fierce bidding war for a “Parasite” limited series that Bong will create with Adam McKay, and I’d expect even more suitors once Bong mounts his feature-film follow-up, especially since he’s said to be working on a new English-language movie.

Still, how big will the “Parasite” halo be when it comes to other international fare? While Netflix invests heavily in acquiring foreign-language films to better serve its worldwide streaming audience, other studios have historically been more hesitant, since the upside at the domestic box office can be limited. It’s possible that a breakthrough like “Parasite,” with its fleet editing and relatable subject matter, can help cultivate a new audience that had previously associated subtitles with glacially paced art films.

It’s just as likely, though, that “Parasite” will pay off only for the films that seem most similar to it. When “Crouching Tiger, Hidden Dragon” became a massive, Oscar-nominated hit in 2000 — with its take of $128.1 million, it’s still the highest-grossing foreign-language import at the U.S. box office — it mainly just paved the way for a handful of other Asian martial-arts films to find domestic distribution. Certainly, studios will be prowling this year’s Cannes Film Festival eager to find the next “Parasite,” but a film as idiosyncratic as Bong’s will prove tough to clone.